MRNA stock · WNC stock

MRNA vs WNC · rev $145.0M vs rev $321.5M

Moderna Inc (MRNA) versus Wabash National Corporation (WNC) — a side-by-side from cached financials, not a winner call.

Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stéphane Bancel M.B.A..

Wabash National Corporation (WNC) is a farm & heavy construction machinery company listed on US.

Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.

Latest reported WNC revenue for 2025-12-31 was $321.5M. Net income was -$49.9M. Revenue was down 22.9% from 2024-12-31 to 2025-12-31. WNC currently screens at market cap $445.4M.

MRNA currently screens at market cap $24.52B. WNC currently screens at market cap $445.4M.

Not investment advice. Open the MRNA and WNC stock pages for the full models.

Not investment advice.

Popular Stock Comparisons